Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type ( Voriconazole, Liposomal, Amphotericin B, Systemic Oral Azoles, Topical, Antifungal Agents, and Others ); Application ( Chronic, Pulmonary Aspergillosis (CPA), Allergic, Bronchopulmonary Aspergillosis (ABPA), Gastrointestinal Candidiasis, Genitourinary Tract Candidiasis, and Others ); and Country

No. of Pages: 96    |    Report Code: TIPRE00020063    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Systemic Aspergillosis and Systemic Candidasis Market – By Type

1.3.2        Systemic Aspergillosis and Systemic Candidasis Market – By Application

1.3.3        Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market – By Geography

2.           Systemic Aspergillosis And Systemic Candidasis Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market– Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Expert Opinions

4.4         Clinical Trials Phases of Products Offered by Companies

4.5         Candida Specific Marketed Products

5.           Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rise in Prevalence of Fungal Diseases

5.1.2        Rising Hospital Acquired Fungal Infection

5.2         Market Restraints

5.2.1        Increasing Resistance to Antifungal Drugs

5.2.2        Side Effects of Antifungal Drugs

5.3         Market Opportunities

5.3.1        Increase in R&D Activities and Pipeline of New Drug

5.4         Future Trends

5.4.1        Consolidation of Market

5.5         Impact Analysis

6.           Systemic Aspergillosis and Systemic Candidasis Market Analysis– by Type

6.1         Overview

6.2         Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)

6.3         Voriconazole

6.3.1        Overview

6.3.2        Asia Pacific Voriconazole Market Revenue and Forecasts to 2027 (US$ Mn)

6.4         Liposomal Amphotericin B

6.4.1        Overview

6.4.2        Asia Pacific Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)

6.5         Systemic Oral Azoles

6.5.1        Overview

6.5.2        Asia Pacific Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)

6.6         Topical Antifungal Agents

6.6.1        Overview

6.6.2        Asia Pacific Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)

6.7         Others

6.7.1        Overview

6.7.2        Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

7.           Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market Analysis– by Application

7.1         Overview

7.2         Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)

7.3         Chronic Pulmonary Aspergillosis (CPA)

7.3.1        Overview

7.3.2        Asia Pacific Chronic pulmonary aspergillosis (CPA) Market Revenue and Forecasts to 2027 (US$ Mn)

7.4         Allergic Bronchopulmonary Aspergillosis (ABPA)

7.4.1        Overview

7.4.2        Asia Pacific Allergic bronchopulmonary aspergillosis (ABPA) Market Revenue and Forecasts to 2027 (US$ Mn)

7.5         Gastrointestinal Candidasis

7.5.1        Overview

7.5.2        Asia Pacific Gastrointestinal Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

7.6         Genitourinary Tract Candidasis

7.6.1        Overview

7.6.2        Asia Pacific Genitourinary Tract Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

7.7         Others

7.7.1        Overview

7.7.2        Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

8.           Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market – Regional Analysis

8.1         Overview

8.1.1        Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.2        Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.3        Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.4        Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market, by Country, 2019 & 2027 (%)

8.1.5        China: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.5.1          China: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.5.2          China: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.5.3          China: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.6        Japan: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.6.1          Japan: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.6.2          Japan: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.6.3          Japan: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.7        India: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.1          India: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.2          India: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.7.3          India: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.8        Australia: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.8.1          Australia: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.8.2          Australia: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.8.3          Australia: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.9        South Korea: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.9.1          South Korea: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.9.2          South Korea: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.9.3          South Korea: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.10     Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.10.1       Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.10.2       Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.10.3       Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

9.           Impact of COVID-19 Pandemic on Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market

9.1         Impact Assessment of COVID-19 Pandemic

10.        COMPANY PROFILES

10.1      Novartis AG

10.1.1     Key Facts

10.1.2     Business Description

10.1.3     Products and Services

10.1.4     Financial Overview

10.1.5     SWOT Analysis

10.1.6     Key Developments

10.2      Sanofi

10.2.1     Key Facts

10.2.2     Business Description

10.2.3     Products and Services

10.2.4     Financial Overview

10.2.5     SWOT Analysis

10.2.6     Key Developments

10.3      Pfizer Inc.

10.3.1     Key Facts

10.3.2     Business Description

10.3.3     Products and Services

10.3.4     Financial Overview

10.3.5     SWOT Analysis

10.3.6     Key Developments

10.4      Merck & Co., Inc.

10.4.1     Key Facts

10.4.2     Business Description

10.4.3     Products and Services

10.4.4     Financial Overview

10.4.5     SWOT Analysis

10.4.6     Key Developments

10.5      Bayer AG

10.5.1     Key Facts

10.5.2     Business Description

10.5.3     Products and Services

10.5.4     Financial Overview

10.5.5     SWOT Analysis

10.5.6     Key Developments

10.6      Astellas Pharma Inc.

10.6.1     Key Facts

10.6.2     Business Description

10.6.3     Products and Services

10.6.4     Financial Overview

10.6.5     SWOT Analysis

10.6.6     Key Developments

10.7      GlaxoSmithKline plc.

10.7.1     Key Facts

10.7.2     Business Description

10.7.3     Products and Services

10.7.4     Financial Overview

10.7.5     SWOT Analysis

10.7.6     Key Developments

10.8      Abbott

10.8.1     Key Facts

10.8.2     Business Description

10.8.3     Products and Services

10.8.4     Financial Overview

10.8.5     SWOT Analysis

10.8.6     Key Developments

10.9      Cipla Inc.

10.9.1     Key Facts

10.9.2     Business Description

10.9.3     Products and Services

10.9.4     Financial Overview

10.9.5     Key Developments

11.        Appendix

11.1      About the Insight Partners

11.2      Glossary of Terms

LIST OF TABLES

Table 1.             Clinical Trials Phases of Products Offered by Companies

Table 2.             Candida Specific Marketed Products

Table 3.             Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.             US: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             China: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027

Table 7.             Japan: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             Japan: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.             India: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 10.          India: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 11.          Australia: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          Australia: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 13.          South Korea: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          South Korea: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.          Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 16.          Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 17.          Glossary of Terms, Systemic Aspergillosis And Systemic Candidasis Market

 

LIST OF FIGURES

Figure 1.           Systemic Aspergillosis And Systemic Candidasis Market Segmentation

Figure 2.           Systemic Aspergillosis And Systemic Candidasis Market, By Region

Figure 3.           Asia Pacific Systemic Aspergillosis And Systemic Candidasis Market Overview

Figure 4.           Systemic Oral Azoles Segment Held Largest Share of Type Segment In Systemic Aspergillosis And Systemic Candidasis Market

Figure 5.           Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           PEST Analysis

Figure 7.           Systemic Aspergillosis and Systemic Candidasis Market Impact Analysis of Drivers and Restraint

Figure 8.           Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market breakdown, by Type, 2019 and 2027 (%)

Figure 9.           Asia Pacific Voriconazole Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 10.        Asia Pacific Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        Asia Pacific Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Asia Pacific Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        Asia Pacific others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market breakdown, by Type, 2019 and 2027 (%)

Figure 15.        Asia Pacific Chronic pulmonary aspergillosis (CPA) Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 16.        Asia Pacific Allergic bronchopulmonary aspergillosis (ABPA)Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        Asia Pacific Gastrointestinal Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        Asia Pacific Genitourinary Tract Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        Asia Pacific others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market, by Key Country – Revenue (2019) (USD Million)

Figure 21.        Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market Revenue and Forecast to 2027 (USD Million)

Figure 22.        Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market, by Country, 2019 & 2027 (%)

Figure 23.        China: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 24.        Japan: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 25.        India: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        Australia: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        South Korea: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Impact of COVID-19 Pandemic on Systemic Aspergillosis And Systemic Candidasis Market in Asia Pacific Countries

 

 

The List of Companies - Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market

  1. Novartis AG
  2. Sanofi
  3. Pfizer Inc.
  4. Merck & Co., Inc.
  5. Bayer AG
  6. Astellas Pharma Inc.
  7. GlaxoSmithKline plc.
  8. Abbott
  9. Cipla Inc.
  10. Enzon Pharmaceuticals, Inc.